ArteDrone, founded by Truffle Capital in 2017, is a MedTech company focused on revolutionizing emergency post stroke mechanical thrombectomy using microrobots controlled by external magnetic field. They operate via a platform that combines robotics and latest AI navigation technology, enabling rapid and effective interventions to address a widely untreated patient pool.